Eli Lilly has struck a deal to purchase genetic-medicine biotechnology firm Orna Therapeutics for as much as $2.4 billion in money.
Source link
Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion
Related Posts
Opinion | The Cost of a Constantly Online Childhood
Teenagers who use social media for 3 or extra hours a day face elevated danger of melancholy and anxiousness. Source…
Naver Posts Resilient Second-Quarter Profit Despite Higher AI Costs
The South Korean web firm posted resilient second-quarter earnings regardless of greater AI-related working prices, supported by stable progress in…
‘Uncanny Valley’: Nvidia’s ‘Super Bowl of AI,’ Tesla Disappoints, and Meta’s VR Metaverse ‘Shutdown’
This week on Uncanny Valley, hosts Brian Barrett and Zoë Schiffer talk about the highlights from Nvidia’s annual developer convention,…